JCR Pharmaceuticals Notice of Organizational Change, Assignment of Responsibilities to a Director and Personnel Changes

JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that organizational change, assignment of responsibilities to a director and personnel changes effective April 1, 2019.
 
1. Organizational change
The ESA Business Support Department will be dissolved in order to optimize allocation of internal resources to priority areas.
 
2. Assignment of Responsibilities to a Director
Name New Title Current Title
Yuji Sato, M.D., Ph.D

Vice President

Head of Research and Development

Vice President

Head of Research and Development Executive Director, Development Division

3. Personnel changes

Name New Title Current Title
Kazunori Tanizawa Executive Director, Development Division Senior Director, Development Division Director, Clinical Development
Tatsuyoshi Yamamoto Director, Clinical Development Group Manager, Clinical Group Vice Director, Clinical Development Group Manager, Clinical Group
Nobuhiro Komatsu Director, Sales Division Director, ESA Business Support Sales Division

To read more People News articles, click here.